Publication | Closed Access

A potential non-invasive glioblastoma treatment: Nose-to-brain delivery of farnesylthiosalicylic acid incorporated hybrid nanoparticles

NanoparticlesNanomedicineNeuro-oncologyCell-based Drug DeliveryEngineeringHybrid NanoparticlesNano-drug DeliveryTumor TargetingNose-to-brain DeliveryBiomedical EngineeringRadiation OncologyMedicineGliomaFarnesylthiosalicylic AcidMolecular Imaging